Français
ItalianoBond AbbVie 3.45% ( US00287YCS63 ) in USD
| Issuer | AbbVie | ||||||||||||||||||||||||||||||||||||||||||
| Market price | 102.52 % ▲ | ||||||||||||||||||||||||||||||||||||||||||
| Country |  United States
|
||||||||||||||||||||||||||||||||||||||||||
| ISIN code |
 US00287YCS63 ( in USD )
|
||||||||||||||||||||||||||||||||||||||||||
| Interest rate | 3.45% per year ( payment 2 times a year) | ||||||||||||||||||||||||||||||||||||||||||
| Maturity | 14/03/2022 - Bond has expired | ||||||||||||||||||||||||||||||||||||||||||
|
Prospectus brochure in PDF format |
|||||||||||||||||||||||||||||||||||||||||||
| Minimal amount | 2 000 USD | ||||||||||||||||||||||||||||||||||||||||||
| Total amount | 2 621 596 000 USD | ||||||||||||||||||||||||||||||||||||||||||
| Cusip | 00287YCS6 | ||||||||||||||||||||||||||||||||||||||||||
| Standard & Poor's ( S&P ) rating | BBB+ ( Lower medium grade - Investment-grade ) | ||||||||||||||||||||||||||||||||||||||||||
| Moody's rating | Baa2 ( Lower medium grade - Investment-grade ) | ||||||||||||||||||||||||||||||||||||||||||
| Detailed description |
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology. The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YCS63, pays a coupon of 3.45% per year. The coupons are paid 2 times per year and the Bond maturity is 14/03/2022 The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YCS63, was rated Baa2 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YCS63, was rated BBB+ ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||